LIPIODOL

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Ecuador, Estonia, France, Hong Kong SAR China, Ireland, Israel, Japan, Malta, New Zealand, Romania, Singapore, Tunisia.

Active ingredients

The drug LIPIODOL contains one active pharmaceutical ingredient (API):

1	Ethyl esters of iodised fatty acids of oleum papaveris UNII KZW0R0686Q - ETHIODIZED OIL
	Read more about Ethiodized oil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V08AD01	Ethyl esters of iodised fatty acids	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AD Non-watersoluble X-ray contrast media
Discover more medicines within V08AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	511000501155412
CA	Health Products and Food Branch	00386685
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5798-MEE-1220
EE	Ravimiamet	1125100
FR	Base de données publique des médicaments	65000980
HK	Department of Health Drug Office	33227
IL	מִשְׂרַד הַבְּרִיאוּת	8917
JP	医薬品医療機器総合機構	7211404X1037
MT	Medicines Authority	AA565/72301, AA565/72302
NZ	Medicines and Medical Devices Safety Authority	595
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65424001
SG	Health Sciences Authority	06035P
TN	Direction de la Pharmacie et du Médicament	5640051
US	FDA, National Drug Code	67684-1901